Nod and wave: An Internet study of the codeine intoxication phenomenon

International Journal of Drug Policy

Volumn 26, Issue 1, 2015, Pages 67-77

  Van Hout, Marie Claire ^a  

^a South East Technological University   (Ireland)

Author keywords

Codeine; Indigenous harm reduction; Internet; Phenomenology

Indexed keywords

CODEINE; OPIATE;

ANESTHESIA; ARTICLE; AWARENESS; CONSCIOUSNESS; DEATH; DISEASE SEVERITY; DISSOCIATIVE EFFECT; DRUG EFFECT; DRUG INTOXICATION; DRUG ISOLATION; DRUG OVERDOSE; DRUG TOLERANCE; DRUG USE; DRUG WITHDRAWAL; EMOTION; EXPERIENCE; FEAR; HUMAN; INTERNET; LEARNING; PAIN; PANIC; PATIENT CARE; PHARMACY; RESPIRATION DEPRESSION; SENSATION; STOMACH PAIN; SYNESTHESIA; THORAX PAIN; WITHDRAWAL SYNDROME; HARM REDUCTION; OPIOID-RELATED DISORDERS; PROCEDURES; PUBLIC HEALTH; RISK MANAGEMENT; SUBSTANCE WITHDRAWAL SYNDROME;

CODEINE; DRUG OVERDOSE; HARM REDUCTION; HUMANS; INTERNET; OPIOID-RELATED DISORDERS; PAIN; PUBLIC HEALTH; RISK MANAGEMENT; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84919837965     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.06.016     Document Type: Article

References (150)

1. Acocella C.M. Using diaries to assess non-prescription drug use among university students. Journal of Drug Education 2005, 35:267-274.
2. Agaba E.I., Agaba P.A., Wigwe C.M. Use and abuse of analgesics in Nigeria: A community survey. Nigerian Journal of Medicine 2004, 13:379-382.
3. Agnich L., Stogner J.M., Miller B.L., Marcum C. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addictive Behaviors 2013, 38:2445-2449.
4. Agyapong V., Sarvage M., Sighn K., Farren C., McLoughlin D. Use of codeine-containing medicines by patients admitted to an acute psychiatric hospital. European Psychiatry 2011, 26:1.
5. Akram G., Roberts K. Pharmacists' management of over-the-counter medication requests from methadone patients. Journal of Substance Use 2003, 8:215-222.
6. Albsoul-Younes A., Wazaify M., Yousef A.M., Tahaineh L. Abuse and misuse of prescription and non-prescription drugs sold in community pharmacies in Jordan. Substance Use and Misuse 2010, 45:1319-1329.
7. Allotey P., Reidpath D.D., Elisha D. "Social medication" and the control of children: A qualitative study of over-the-counter medication among Australian children. Pediatrics 2004, 114:e378-e383.
8. Arora S., Herbert M.E. Myth: Codeine is a powerful and effective analgesic. Western Journal of Medicine 2001, 174:428. 18.
9. Ayonrinde O.T., Phelps G.J., Hurley J.C., Ayonrinde O.A. Paracetamol overdose and hepatotoxicity at a regional Australian hospital: A 4-year experience. Internal Medicine Journal 2005, 35:655-660.
10. Bailey J.A., Hurley R.W., Gold M.S. Crossroads of pain and addiction. Pain Medicine 2010, 11:1803-1818.
11. Band C.J., Band P.R., Deschamps M., Besner J.G., Coldman A.J. Human pharmacokinetic study of immediate-release (codeine phosphate) and sustained-release (codeine Contin) codeine. Journal of Clinical Pharmacology 1994, 34:938-943.
12. Barbera N., Busardo F.P., Indorato F., Romano G. The pathogenetic role of adulterants in 5 cases of drug addicts with a fatal outcome. Forensic Science International 2013, 227:74-76.
13. Barkin R.L. Acetaminophen, aspirin, or ibuprofen in combination analgesic products. American Journal of Therapeutics 2001, 8(6):433-442.
14. Barrett S.P., Meisner J.R., Stewart S.H. What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations. Current Drug Abuse Reviews 2008, 1:255-262.
15. Becker H.S. Outsiders: Studies in the sociology of deviance 1963, Macmillan, New York.
16. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., Leone S. Paracetamol: New vistas of an old drug. CNS Drug Reviews 2006, 12:250-275.
17. Boyer E.W., Lapen P.T., Macalino G., Hibberd P.L. Dissemination of psychoactive substance information by innovative drug users. Cyberpsychology and Behavior: The Impact of the Internet, Multimedia and Virtual Reality on Behavior and Society 2007, 10(1):1-6.
18. Brady J.E., Wunsch H., DiMaggio C., Lang B.H., Giglio J., Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Reports 2014, 129(2):139-147.
19. Casati A., Sedefov R., Pfeiffer-Gerschel T. Misuse of medicines in the European Union: A systematic review of the literature. European Addiction Research 2012, 18:228-245.
20. Cepeda M.S., Fife D., Chow W., Mastrogiovanni G., Henderson S.C. Opioid shopping behavior: How often, how soon, which drugs, and what payment method. Journal of Clinical Pharmacology 2013, 53(1):112-117.
21. Chenail R.J. Qualitative researchers in the blogosphere: Using blogs as diaries and data. Qualitative Report 2011, 16(1):249-254.
22. Chetty R., Baoku Y., Mildner R., Bannerjee A., Vallance D., Haddon A., et al. Severe hypokalaemia and weakness due to Nurofen misuse. Annals of Clinical Biochemistry 2003, 40:422-423.
23. Cohen D.P., Unoh E., Barry H., O'Connor J.J. Codeine misuse among service users on a methadone treatment programme. Irish Journal of Medical Science 2009, 179:465.
24. Cone E.J. Ephemeral profiles of prescription drug and formulation tampering: Evolving pseudoscience on the Internet. Drug and Alcohol Dependence 2006, 83:S31-S39.
25. Cooper R.J. Over-the-counter medicine abuse: A review of the literature. Journal of Substance Use 2013, 18:82-107.
26. Cooper R. 'I can't be an addict, I am.' Over-the-counter medicine abuse: A qualitative study. BMJ Open 2013, 3.
27. Cunliffe M. Codeine phosphate in children: Time for re-evaluation?. British Journal of Anaesthesia 2001, 86:329-331.
28. Dalgarno P., Shewan D. Reducing the risks of drug use: The case for set and setting. Addiction Research and Theory 2005, 13:259-265.
29. Day K., Keys T. Starving in cyberspace: A discourse analysis of pro-eating disorder websites. Journal of Gender Studies 2008, 17(1):1-15.
30. Derry S.M. Single dose codeine, as a single agent, for acute post operative pain in adults. Cochrane Database Systematic Review 2010, 14:CD008099.
31. Derry S., Karlin S.M., Moore R.A. Single dose oral ibuprofen plus codeine for acute postoperative pain in adults (Review) 3. The Cochrane Database Systematic Review 2013.
32. DiMaggio P., Hargittai E., Neuman W.R., Robinson J.P. Social implications of the Internet. Annual Review of Sociology 2001, 27:307-336.
33. Dobbin M., Tobin C. Over-the-counter, (OTC) ibuprofen/codeine analgesics: Misuse and harm 2008, Drugs Policy and Services Branch, Department of Human Services, Victoria, Melbourne, Australia.
34. Duff C. Drug use as a 'practice of the self': Is there any place for an 'ethics of moderation' in contemporary drug policy?. International Journal of Drug Policy 2004, 15:385-393.
35. Dutch M.J. Nurofen Plus misuse: An emerging cause of perforated gastric ulcer. Medical Journal of Australia 2008, 188:56-57.
36. Dyer B.T., Martin J.L., Mitchell J.L., Sauven N.C., Gazzard B. Hypokalaemia in ibuprofen and codeine phosphate abuse. International Journal of Clinical Practice 2004, 58:1061-1062.
37. Elwood W.N. Sticky business: Patterns of procurement and misuse of prescription cough syrup in Houston. Journal of Psychoactive Drugs 2001, 33:121-133.
38. Erickson F. The meaning of validity in qualitative research. Handbook of Research on Teaching 1989, Macmillan, New York. M.C. Wittrock (Ed.).
39. Ernest D., Chia M., Corallo C.E. Profound hypokalaemia due to Nurofen Plus and Red Bull. Critical Care and Resuscitation 2010, 12:109-110.
40. Evans C., Gearry R.B. Combination NSAID-codeine preparations and gastrointestinal toxicity. New Zealand Medical Journal 2010, 123:92-93.
41. Fischer B., Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: A review. Pain Physician 2012, 15(Suppl. 3):ES191-ES203.
42. Fischer B., Bibby M., Bouchard M. The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of sourcing routes and control measures. Addiction 2010, 105(12):2062-2070.
43. Ford J.A. Misuse of over-the-counter cough or cold medications among adolescents: Prevalence and correlates in a national sample. Journal of Adolescent Health 2009, 44:505-507.
44. Franceschi F., Iacomini P., Marsiliani D., Cordischic C., Forte E., Antonini S., et al. Safety and efficacy of the combination Acetaminophen-Codeine in the treatment of pain of different origin. European Review for Medical and Pharmacological Sciences 2013, 17:2129-2135.
45. Francis S.A., Barnett N., Denham M. Switching of prescription drugs to over-the-counter status: Is it a good thing for the elderly?. Drugs Aging 2005, 22(5):361-370.
46. Frei M.Y., Nielsen S., Dobbin M.D., Tobin C.L. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: A series of 27 cases. Medical Journal Australia 2010, 193:294-296.
47. Fredheim O.M.S., Skurtveit S., MorozA, Breivik H., Borchgrevink P.C. Prescription pattern of codeine for non-malignant pain: A pharmacoepidemiological study from the Norwegian Prescription Database. Acta Anaesthesiological Scandinavica 2009, 53:627-633.
48. Friedman S., de Jong W., Rossi D., Touźe G., Rockwell R., Des Jarlais D., et al. Harm reduction theory: Users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups. International Journal of Drug Policy 2007, 18:107-117.
49. Friedrichs H. Die Psychologie des Meskalinrausches 2009, VWB - Verlag für Wissenschaft und Bildung, Berlin.
50. Gamble L., George M. 'Really useful knowledge': The boundaries, customs, and folklore governing recreational drug use in a sample of young people. Harm reduction: A new direction for drug policies and programs 1997, 341-362. University of Toronto Press, Toronto. P.G. Erickson, D.M. Riley, Y.W. Cheung, P.A. O'Hare (Eds.).
51. Gilson A.M., Kreis P.G. The burden of the nonmedical use of prescription opioid analgesics. Pain Medicine 2009, 10:S89-S100.
52. Green T.C., Bowman S.E., Ray M., Zaller N., Heimer R., Case P. Collaboration or coercion? Partnering to divert prescription opioid medications. Journal of Urban Health 2013, 90(4):758-767.
53. Greenspan N.R., Aguinaldo J.P., Husbands W., Murray J., Ho P., Sutdhibhasilp N., et al. "It's not rocket science, what I do": Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual men. International Journal of Drug Policy 2011, 22:56-62.
54. Greyson B. Near-death experiences in a psychiatric outpatient clinic population. Psychiatric Services 2003, 54:1649-1651.
55. Gudin J.A. Clinical strategies for the primary health care professional to minimize prescription opioid abuse. Postgraduate Medicine 2012, 124(3):131-138.
56. Hamill-Ruth R.J., Larriviere K., McMasters M.G. Addition of objective data to identify risk for medication misuse and abuse: The inconsistency score. Pain Medicine 2013, 14(12):1900-1907.
57. Hamer A., Spark J., Wood P., Roberts E. The upscheduling of combination analgesics containing codeine: The impact on the practice of pharmacists. Research in Social and Administrative Pharmacy 2013, (October). pii: S1551-7411(13)00154-X [Epub ahead of print]. 10.1016/j.sapharm.2013.08.004.
58. Hansen D., Maycock B., Lower T. 'Weddings, parties, anything.', a qualitative analysis of ecstasy use in Perth, Western Australia. International Journal of Drug Policy 2001, 12:181-199.
59. Heard K., Sloss D., Weber S., Dart R.C. Overuse of over-the-counter analgesics by emergency department patients. Annals of Emergency Medicine 2006, 28:315-318.
60. Hersh E.V., Pinto A., Moore P.A. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clinical Therapeutics 2007, 29:2477-2497.
61. Holt M., Treloar C. Managing mental health problems in everyday life: Drug treatment clients' self-care strategies. International Journal of Mental Health and Addiction 2008, 6:421-431.
62. Hsiung R.C. The best of both worlds: An online self-help group hosted by a mental health professional. Cyber Psychology & Behavior 2000, 3(6):935-950.
63. Huffman D.H., Ferguson R.L. Acute codeine overdose: Correspondence between clinical course and codeine metabolism. Johns Hopkins Medical Journal 1975, 136:183-186.
64. Husserl E. Logical investigation 1970, Humanities Press, New York.
65. Iedema J. Cautions with codeine. Australian Prescriber 2011, 34:133-135.
66. Inciardi J.A., Surratt H.L., Cicero T.J., Rosenblum A., Ahwah C., Bailey J.E., et al. Prescription drugs purchased through the Internet: Who are the users?. Drug and Alcohol Dependence 2010, 110(1-2):21-29.
67. Inciardi J.A., Surratt H.L., Kurtz S.P., Cicero T.J. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine 2007, 8:171-183.
68. Inciardi J.A., Surratt H.L., Cicero T.J., Kurtz S.P., Martin S.S., Parrino M.W. The "black box" of prescription drug diversion. Journal of Addictive Diseases 2009, 28(4):332-347.
69. Inciardi J.A., Surratt H.L., Cicero T.J., Roseblum A., Ahwah C., Bailey E., et al. Prescription drugs purchased through the Internet: Who are the end users?. Drug and Alcohol Dependence 2010, 110:21-29.
70. Ingelman-Sundberg M., Sim S.C., Gomez A., Rodriguez-Antona C. Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacology and Therapeutics 2007, 116:496-526.
71. Jacinto C., Duterte M., Sales P., Murphy S. Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks. International Journal of Drug Policy 2008, 19:393-400.
72. Jones J.D., Mogali S., Comer S.D. Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence 2012, 125:8-18.
73. Karlsson G. Psychological qualitative research from a phenomenological perspective 1995, Almqvist & Wiksell International, Stockholm, Sweden.
74. Kelly L.E., Madadi P. Is there a role for therapeutic drug monitoring with codeine?. Therapeutics and Drug Monitoring 2012, 34:249-256.
75. Kelly P.A. Pharmacogenomics: Why standard codeine doses can have serious toxicities or no therapeutic effect. Oncology Nursing Forum 2013, 40:322-324.
76. Kintz P., Tracqui A., Mangin P. Codeine concentrations in human samples in a case of fatal ingestion. International Journal of Legal Medicine 1991, 104(3):177-178.
77. Kjellgren A., Henningsson H., Soussan C. Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum. Substance Abuse 2013, 27(7):191-198.
78. Kjellgren A., Jonsson K. Methoxetamine (MXE) - A Phenomenological Study of Experiences Induced by a "Legal High" from the Internet. Journal of Psychoactive Drugs 2013, 45(3):276-286.
79. Kjellgren A., Soussan C. Heaven and hell-a phenomenological study of recreational use of 4-HO-MET in Sweden. Journal of Psychoactive Drugs 2011, 43(3):211-219.
80. Klüver H. Mescal and mechanisms of hallucinations 1966, University of Chicago Press, Chicago.
81. Kozinets R.V. On netnography: Initial reflections on consumer research investigations of cyberculture. Advances in Consumer Research 1998, 25(1):366-371.
82. Kramish C.M., Meier A., Carr C., Enga Z., James A.S., Reedy J. Health behavior changes after colon cancer: A comparison of findings from face-to-face and on-line focus groups. Family and Community Health 2001, 24:88-103.
83. Lam C.M., Shek D. A qualitative study of cough medicine abuse among Chinese young people in Hong Kong. Journal of Substance Abuse 2006, 11:233-244.
84. Lambert A.P., Close C. Life-threatening hypokalaemia from abuse of Nurofen Plus. Journal of the Royal Society of Medicine 2005, 98:21.
85. Lao Y.Z., Jiang Z.Y., Tong Z.S., Pang Z.T., Xu J.X. Clinical features and defense styles in patients with cough medicine abuse. Medical Journal of Chinese People's Health 2010, 22:272-274.
86. Lessenger J.E., Feinberg S.D. Abuse of prescription and over-the-counter medications. Journal of the American Board of Family Medicine 2008, 21:45-54.
87. Malek-Ahmadi P., Ramsey M.L. Acute psychosis associated with codeine and acetaminophen: A case report. Neurobehavioral Toxicology and Teratology 1985, 7:193-194.
88. Manchikanti L., Abdi S., Atluri S., Balog C., Benyamin C., Boswell R.M., et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain. Part 2. Guidance. Pain Physician 2012, 15(Suppl. 3):S67-S116.
89. Markham A. Reconsidering self and other: The methods, politics, and ethics of representation in online ethnography. Handbook of qualitative research 2005, 101-124. Sage, Thousand Oaks, CA. N.K. Denzin, Y.S. Lincoln (Eds.).
90. Martyres R.F., Clode D., Burns J. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. MJA 2004, 180:211-214.
91. Maxwell J.A. Understanding and validity in qualitative research. Harvard Educational Review 1992, 62(3):279-301.
92. McClain C.J., Price S., Barve S., Devalaria R., Shedlofsky S. Acetaminophen hepatotoxicity: An update. Current Gastroenterology Reports 1999, 1:42-49.
93. McDonough M.A. Misuse of codeine-containing combination analgesics. Medical Journal of Australia 2011, 194(9):486.
94. Mottern R. Teacher-student relationships in court-mandated adult education: A phenomenology study. Qualitative Report 2013, 18:1-40.
95. Myers B., Siegfried N., Parry C.D. Over-the-counter and prescription medicine misuse in Cape Town - Findings from specialist treatment centres. South African Medical Journal 2003, 93:367-370.
96. Myers T., Aggleton P., Kippax S. Perspectives on harm reduction: Editorial introduction. Critical Public Health 2004, 14:325-328.
97. Neutel C.I., Skurtveit S., Berg C., Sakshaug S. Multiple prescribers in older frequent opioid users - Does it mean abuse?. Journal of Population Therapeutics and Clinical Pharmacology 2013, 20(3):e397-e405.
98. Nielsen S., Cameron J., Lee N. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: Implications for intervention and prevention. Journal of Opioid Management 2011, 7(5):363-370.
99. Nielsen S., Cameron J., Lee N. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: Implications for intervention and prevention. Journal of Opioid Management 2011, 7:363-370.
100. Nielson S., Bruno R., Carruthers S., Fischer J., Lintzeris N., Stoove M. Investigation of pharmaceutical misuse amongst drug treatment clients 2008, Turning Point Alcohol and Drug Centre, Victoria, Australia.
101. Nielson S., Cameron J., Pahoki S. Over the counter codeine dependence 2010, Turning Point Drug and Alcohol Centre, Victoria, Australia.
102. Nordmann S., Pradel V., Lapeyre-Mestre M., Frauger E., Pauly V., Thirion X., et al. Doctor shopping reveals geographical variations in opioid abuse. Pain Physician 2013, 16:89-100.
103. Panagopoulos I., Ricciardelli L.A. Harm reduction and decision making among recreational ecstasy users. International Journal of Drug Policy 2005, 16:54-64.
104. Patton M.Q. Qualitative evaluation and research method 2002, Sage Publications Inc., Thousand Oaks, CA.
105. Peirce G.L., Smith M.J., Abate M.A., Halverson J. Doctor and pharmacy shopping for controlled substances. Medical Care 2012, 50(6):494-500.
106. Peters R.J., Kelder S.H., Markham C.M., Yacoubian G.S., Peters L.A., Ellis A. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among urban Houstonian adolescents: An addiction trend in the city of lean. Journal of Drug Education 2003, 33:415-425.
107. Peters R.J., Amos C., Meshack A., Savage C., Sinclair M.M., Williams L.T., et al. Codeine cough syrup use among sexually active, African-American high school youths: Why southern males are down to have sex. American Journal on Addictions 2007, 16:144-145.
108. Peters R.J., Williams M., Ross M.W., Atkinson J., Yacoubian G.S. Codeine cough syrup use among African-American crack cocaine users. Journal of Psychoactive Drugs 2007, 39:97-102.
109. Peters R.J., Yacoubian G.S., Rhodes W., Forsythe K.J., Bowers K.S., Eulian V.M., et al. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. Journal of Psychoactive Drugs 2007, 39:277-282.
110. Pilgrim J.L., Dobbin M., Drummer O.H. Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Medical Journal of Australia 2013, 199(5):329-331.
111. Pilgrim J.L., Drummer O.H. Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. In reply. Medical Journal of Australia 2014, 200(3):151.
112. Roumie C.L., Griffin M.R. Over-the-counter analgesics in older adults, a call for improved labelling and consumer education. Drugs and Aging 2004, 21:485-498.
113. Saba V.K., McCormick K.A. Essentials of computers for nurses: Informatics for the new millennium 2001, McGraw-Hill, New York.
114. Schmidt L.E., Dalhoof K. Concomitant overdosing of other drugs in patients with paracetamol poisoning British. Journal of Clinical Pharmacology 2002, 53:535-541.
115. Sehgal N., Manchikanti L., Smith H.S. Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician 2012, 15(Suppl. 3):ES67-ES92.
116. Servis M., Connolly B. Acute psychosis, associated with acetaminophen overdose. General Hospital Psychiatry 1997, 19:149-152.
117. Shand F.L., Campbell G., Hall W., Lintzeris N., Cohen M., Degenhardt L. Real-time monitoring of Schedule 8 medicines in Australia: Evaluation is essential. Medical Journal of Australia 2013, 198(2):80-81.
118. Shanon B. The antipodes of the mind 2002, Oxford University Press, Oxford, New York.
119. Shaw K.D., Amstutz U., Jimenez-Mendez R., Ross C.J., Carleton B.C. Suspected opioid overdose case resolved by CYP2D6 genotyping. Therapeutic Drug Monitoring 2012, 34:121-123.
120. Sheen C.L., Dillon J.F., Bateman D.N., Simpson K.J., Macdonald T.M. Paracetamol toxicity: Epidemiology, prevention and costs to the health-care system. QJM 2002, 95:609-619.
121. Shek D.T.L., Lam C.M. Beliefs about cough medicine abuse among Chinese young people in Hong Kong. Social Behavior and Personality 2008, 36:135-144.
122. Shek D.T., Lam C.M. Adolescent cough medicine abuse in Hong Kong: Implications for the design of positive youth development programs in Hong Kong. International Journal of Adolescent Med. Health 2006, 18:493-503.
123. Shepherd J. Combating the prescription painkiller epidemic: A national prescription drug reporting program. American Journal of Law and Medicine 2014, 40(1):85-112.
124. Shewan D., Dalgarno P., Reith G. Perceived risk and risk reduction among ecstasy users: The role of drug, set, and setting. International Journal of Drug Policy 2000, 10:432-453.
125. Sinke C., Halpern J.H., Zedler M., Neufeld J., Emrich H.M., Passie T. Genuine and drug-induced synesthesia: A comparison. Consciousness and Cognition 2012, 21:1419-1434.
126. Smith A., Stewart B. Body conceptions and virtual ethnopharmacology in an online bodybuilding community. Performance Enhancement & Health 2012, 1:35-38.
127. Solowij N., Hall W., Lee N. Recreational MDMA use in Sydney: A profile of "Ecstasy" users and their experiences with the drug. British Journal of Addiction 1992, 87:1161-1172.
128. Southgate E., Hopwood M. The role of folk pharmacology and lay experts in harm reduction: Sydney gay drug using networks. International Journal of Drug Policy 2001, 12:321-335.
129. Sweileh W.M., Arafat R.T., Al-Khyat L.S., Al-Masri D.M., Jaradat N.A. A pilot study to investigate over-the-counter drug abuse and misuse in Palestine. Saudi Medical Journal 2004, 25(12):2029-2032.
130. Tang A.K., Tang W.K., Liang H.J., Chan F., Mak S.C., Ungvari G.S. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: A retrospective study. East Asian Archives of Psychiatry 2012, 22:154-159.
131. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., Sullivan L.E. Gender and non-medical use of prescription opioids: Results from a national US survey. Journal of Addiction 2007, 103:258-268.
132. Thekiso B., Farren C. Over the counter' (OTC) opiate abuse treatment. Irish Journal of Psychological Medicine 2010, 27:189-191.
133. Thomas S.P., Pollio H.R. Listening to patients: A phenomenological approach to nursing research and practice 2002, Springer, New York, NY.
134. Toblin R.L., Paulozzi L.J., Logan J.E., Hall A.J., Kaplan J.A. Mental illness and psychotropic drug use among prescription drug overdose deaths: A medical examiner chart review. Journal of Clinical Psychiatry 2010, 71(4):491-496.
135. Toms L., Derry S., Moore R.A., McQuay H.J. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Systematic Review 2009, 21:CD001547.
136. Tremlett M., Anderson B.J., Wolf A. Pro-con debate: Is codeine a drug that still has a useful role in pediatric practice?. Paediatric Anaesthesia 2010, 20:183-194.
137. UNODC The non medicinal use of prescription drugs. Discussion paper 2011, UNODC, Vienna.
138. Van Hout M.C., Bingham T. 'Surfing the Silk Road': A study of users' experiences. International Journal of Drug Policy 2013, 24(6):524-529.
139. Wang K.H., Becker W., Fiellin D.A. Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents. Drug and Alcohol Dependence 2013, 127:156-162.
140. Wazaify M., Shields E., Hughes C.M., McElnay J.C. Societal perspectives on over-the-counter (over the counter) medicines. Family Practice 2005, 22:170-176.
141. Wertz F.J. Phenomenological research methods for counseling psychology. Journal of Counseling Psychology 2005, 52:167-177.
142. White A.G., Birnbaum H.G., Schiller M., Tang J., Katz N.P. Analytic models to identify patients at risk for prescription opioid abuse. American Journal of Managed Care 2009, 15:897-906.
143. Wilsey B.L., Fishman S.M., Gilson A.M., Casamalhuapa C., Baxi H., Zhang H., et al. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug and Alcohol Dependence 2010, 112(1-2):99-106.
144. Wilson K.M., Singh P., Blumkin A.K., Dallas L., Klein J.D. Knowledge gaps and misconceptions about over-the-counter analgesics among adolescents attending a hospital-based clinic. American Academy of Pediatrics 2010, 10:228-232.
145. Wilson S.M., Peterson L.C. The anthropology of online communities. Annual Review of Anthropology 2002, 31:449-467.
146. Wittel A. Ethnography on the move: From field to net to Internet. Forum: Qualitative social research 2000, Retrieved from: http://www.qualitative-research.net/index.php/fqs/article/view/1131/2517 (06.05.14).
147. Worley J. Prescription drug monitoring programs, a response to doctor shopping: Purpose, effectiveness, and directions for future research. Issues in Mental Health Nursing 2012, 33(5):319-328.
148. Yang Y., Yuan Q.Y. Investigation and analysis on personalities of male - codeine phosphate addicts by MMPI. Chinese Journal of Drug Abuse Prevention and Treatment 2008, 14:143-145.
149. Zhou S. Polymorphism of human cytochrome P450 2D6 and its clinical significance. Part 1. Clinical Pharmacokinetics 2009, 48:689-723.
150. Zinberg N.E. Drug, set, and setting: The basis for controlled intoxicant use 1984, Yale University Press, New Haven.